How To Fight Prostate Cancer & Win
by William L. Fischer. Probably the single most important book we would recommend for those with prostate problemsmore info...
NEW! . . . SUPER FOODS FOR A SUPER-HEALTHY YOU
Unleash the secret healing power of Nature's ultimate foods - & 'programme' your body to remain free of illnessmore info...
Cancer
Gardasil Is Not The ‘Fairytale Cancer Vaccine’ It Is Dressed Up To Be
Date: 23/04/09
This is an article I recommend you to a friend, an aunt, or niece or cousin or a female colleague... or any parent.
Cervical cancer!
It’s been in the news since September last year with a massive national awareness campaign since Jade Goody was diagnosed with it. But for our regular readers here at the Daily Health it will even hit a little closer to home: HSI Director, Jenny Thompson (you’ve all had an email from her in your inbox beginning of the week) is a cervical cancer survivor. And it is after receiving an email from her today that I am writing this urgent message to you.
Jenny has produced this video to alert everyone to the dangers of Gardasil. You can view it here:
Gardasil: 32 girls have died
In September 2008 the Department of Health (DOH) introduced a HPV immunisation programme to routinely vaccinate girls aged 12 - 13 against cervical cancer. A catch-up programme will start in Autumn 2009 when girls aged 16 - 18 will be offered the vaccine.
There are more than 100 subtypes of the human papilloma virus (HPV) and most women who are sexually active will have had the virus at some stage in their life. Usually, the body’s natural defences defeat the virus, and most women never even know they had it in the first place.
Exposure to certain strains of HPV induces changes in some cells in the cervix. These affected cells can potentially go on to develop cervical intra-epithelial neoplasia (CIN, sometimes called dysplasia or dyskaryosis), and progress into cervical cancer.
The new human papilloma virus (HPV) vaccine, named Gardasil, is effective against four major HPV strains or subtypes. Gardasil has been granted a licence by the EU for use in children and adolescents aged 9 to 15 years and in adult females aged 16 to 26 years for the prevention of cervical cancer caused by human papilloma virus (HPV) types 6, 11, 16, and 18.
Sounds good, doesn’t it?
NO!
So far, more than 11,900 girls and young women have reported adverse events - including paralysis, coma, seizures and more.
The number of deaths reported is currently between 32 and 45, based on different sources. That number may seem statistically low compared to the number of girls that have received it, but if it were your daughter, the statistics wouldn't matter.
There are more than 100 subtypes of the human papilloma virus. Gardasil is effective against ONLY four strains. Does this mean we have to wait for 96 more dangerous vaccines to be developed for ‘protection’ against the rest of these strains? Risking more lives and more adverse effects? Feeding the money-hungry pockets of pharmaceutical giants, whilst there are other effective alternatives available such as screening and smear tests…
Minor side-effects
The vaccine maker Merck says there is no link between Gardasil and serious adverse events and stick to their guns by saying that the vaccine is usually well tolerated; the most likely side effects include - pain, itching, swelling at the injection site, fever, nausea, and dizziness...
Yet in the US, The National Vaccine Information Centre, a private vaccine-safety group, compared Gardasil adverse events to another vaccine, one also given to young people, but for meningitis. Gardasil had three times the number of Emergency Room visits - more than 5,000 and reports of side effects were up to 30 times higher with Gardasil.
‘I think there are too many people having serious long-term side-effects,’ said Dr. Dwight after treating a young girl who suffered seizures, strokes and heart problems after receiving her Gardasil jab.
‘If I’d have known, we never would have gotten the shot,’ said Emily Tarsell, whose daughter, Chris, died three weeks after her third Gardasil shot. She was one of the fatalities reported in the past two years. “And she’d be here to hug.”
While all of this is going on, Merck has asked the American Food and Drug Administration (FDA) to approve it for boys, who can pass on the cancer-causing virus to girls, meaning the number of people getting Gardasil may double. And it doesn’t stop there... A report from Bloomberg earlier this year said:
‘Sales of Merck’s Gardasil, a vaccine against cervical cancer, fell 16 per cent to $286 million, with U.S. revenue declining 19 per cent. The vaccine, approved in 2006 in girls and women ages 9 to 26, has failed to catch on with young adults within that age group. Patients may also be skipping the $400 shot because of the recession, analysts said.
Merck is intensifying Gardasil marketing to young women ages 18 to 26 who have been least likely to get the vaccine. The company mailed 2.5 million Gardasil advertisements to patients and enrolled 6,500 doctors in a programme to reimburse them for the cost of administering the shots if health insurers refuse to pay.’
But as you’ll hear when you view the video, Jenny firmly believes that better screening and more frequent smear tests to curb cervical cancer rates – not a drug that endangers the lives of children and lines the pockets of manufacturers.
I urge to look at this video again and share it with as many people as you can. It could save a child’s life…
You can also read more about our take on Gardasil when it first was FDA approved by following the link below:
Cervical Cancer Vaccine: Should It Be Mandatory For Young Girls?
Sources:
‘Vaccination against cervical cancer’ published online, oxfordradcliffe.nhs.uk
‘Cervical Cancer – Gardasil’, published online, fleetstreetclinic.com
‘Gardasil…KILLS!’ by irdial, published online 09.02.09, irdial.com/blogdial
‘Merck’s Profit Beats Analysts’ Estimates, Shares Gain’ by Shannon Pettypiece, published online 03.02.09, bloomberg.com
Back to topCervical cancer!
It’s been in the news since September last year with a massive national awareness campaign since Jade Goody was diagnosed with it. But for our regular readers here at the Daily Health it will even hit a little closer to home: HSI Director, Jenny Thompson (you’ve all had an email from her in your inbox beginning of the week) is a cervical cancer survivor. And it is after receiving an email from her today that I am writing this urgent message to you.
Jenny has produced this video to alert everyone to the dangers of Gardasil. You can view it here:
Gardasil: 32 girls have died
In September 2008 the Department of Health (DOH) introduced a HPV immunisation programme to routinely vaccinate girls aged 12 - 13 against cervical cancer. A catch-up programme will start in Autumn 2009 when girls aged 16 - 18 will be offered the vaccine.
There are more than 100 subtypes of the human papilloma virus (HPV) and most women who are sexually active will have had the virus at some stage in their life. Usually, the body’s natural defences defeat the virus, and most women never even know they had it in the first place.
Exposure to certain strains of HPV induces changes in some cells in the cervix. These affected cells can potentially go on to develop cervical intra-epithelial neoplasia (CIN, sometimes called dysplasia or dyskaryosis), and progress into cervical cancer.
The new human papilloma virus (HPV) vaccine, named Gardasil, is effective against four major HPV strains or subtypes. Gardasil has been granted a licence by the EU for use in children and adolescents aged 9 to 15 years and in adult females aged 16 to 26 years for the prevention of cervical cancer caused by human papilloma virus (HPV) types 6, 11, 16, and 18.
Sounds good, doesn’t it?
NO!
So far, more than 11,900 girls and young women have reported adverse events - including paralysis, coma, seizures and more.
The number of deaths reported is currently between 32 and 45, based on different sources. That number may seem statistically low compared to the number of girls that have received it, but if it were your daughter, the statistics wouldn't matter.
There are more than 100 subtypes of the human papilloma virus. Gardasil is effective against ONLY four strains. Does this mean we have to wait for 96 more dangerous vaccines to be developed for ‘protection’ against the rest of these strains? Risking more lives and more adverse effects? Feeding the money-hungry pockets of pharmaceutical giants, whilst there are other effective alternatives available such as screening and smear tests…
Minor side-effects
The vaccine maker Merck says there is no link between Gardasil and serious adverse events and stick to their guns by saying that the vaccine is usually well tolerated; the most likely side effects include - pain, itching, swelling at the injection site, fever, nausea, and dizziness...
Yet in the US, The National Vaccine Information Centre, a private vaccine-safety group, compared Gardasil adverse events to another vaccine, one also given to young people, but for meningitis. Gardasil had three times the number of Emergency Room visits - more than 5,000 and reports of side effects were up to 30 times higher with Gardasil.
‘I think there are too many people having serious long-term side-effects,’ said Dr. Dwight after treating a young girl who suffered seizures, strokes and heart problems after receiving her Gardasil jab.
‘If I’d have known, we never would have gotten the shot,’ said Emily Tarsell, whose daughter, Chris, died three weeks after her third Gardasil shot. She was one of the fatalities reported in the past two years. “And she’d be here to hug.”
While all of this is going on, Merck has asked the American Food and Drug Administration (FDA) to approve it for boys, who can pass on the cancer-causing virus to girls, meaning the number of people getting Gardasil may double. And it doesn’t stop there... A report from Bloomberg earlier this year said:
‘Sales of Merck’s Gardasil, a vaccine against cervical cancer, fell 16 per cent to $286 million, with U.S. revenue declining 19 per cent. The vaccine, approved in 2006 in girls and women ages 9 to 26, has failed to catch on with young adults within that age group. Patients may also be skipping the $400 shot because of the recession, analysts said.
Merck is intensifying Gardasil marketing to young women ages 18 to 26 who have been least likely to get the vaccine. The company mailed 2.5 million Gardasil advertisements to patients and enrolled 6,500 doctors in a programme to reimburse them for the cost of administering the shots if health insurers refuse to pay.’
But as you’ll hear when you view the video, Jenny firmly believes that better screening and more frequent smear tests to curb cervical cancer rates – not a drug that endangers the lives of children and lines the pockets of manufacturers.
I urge to look at this video again and share it with as many people as you can. It could save a child’s life…
You can also read more about our take on Gardasil when it first was FDA approved by following the link below:
Cervical Cancer Vaccine: Should It Be Mandatory For Young Girls?
Sources:
‘Vaccination against cervical cancer’ published online, oxfordradcliffe.nhs.uk
‘Cervical Cancer – Gardasil’, published online, fleetstreetclinic.com
‘Gardasil…KILLS!’ by irdial, published online 09.02.09, irdial.com/blogdial
‘Merck’s Profit Beats Analysts’ Estimates, Shares Gain’ by Shannon Pettypiece, published online 03.02.09, bloomberg.com
Click here to send to a friendShare thisPrinter friendly version
